Catheter Precision
VTAK
13 hedge funds and large institutions have $74.2M invested in Catheter Precision in 2018 Q3 according to their latest regulatory filings, with 13 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$4.54M |
| 2 |
BAMCO Inc
New York
|
+$4.54M |
| 3 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
+$4.54M |
| 4 |
DM
Deerfield Management
New York
|
+$4.54M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$4.54M |
Top Sellers
VTAK Hedge Fund Activity: Q3 2018 in Review
13 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Catheter Precision (VTAK) for Q3 2018, worth a combined $74.2M.
Buyers outnumbered sellers: 13 funds opened new VTAK positions and 0 closed out — a net gain of 13 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was ArrowMark Colorado Holdings, opening a new position worth an estimated $4.54M.
- 13 institutional investors held Catheter Precision (VTAK) as of Q3 2018, up from 0 in Q2 2018.
- Funds reported $74.2M of Catheter Precision stock for Q3 2018.
- 13 funds opened new Catheter Precision positions in Q3 2018 and 0 closed out, a net change of +13 holders.
- The largest Catheter Precision buyer in Q3 2018 was ArrowMark Colorado Holdings, an estimated $4.54M added.
Based on aggregated 13F filings for Q3 2018.